CAIRNS Et Al-2010-Journal of Oral Rehabilitation

download CAIRNS Et Al-2010-Journal of Oral Rehabilitation

of 9

Transcript of CAIRNS Et Al-2010-Journal of Oral Rehabilitation

  • 8/18/2019 CAIRNS Et Al-2010-Journal of Oral Rehabilitation

    1/9

    Commentary

    JOR-CORE recommendations on rehabilitation of

    temporomandibular disorders

    B . C A I R N S * , T . L I S T , A . M I C H E L O T T I , R . O H R BA C H§ & P . S V E NS S O N¶   *Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada,   Department of Stomatognathic Physiology, Faculty

    of Odontology, Orofacial Pain Unit, Malmö University, Malmö, Sweden,   Department of Oral, Dental and Maxillo-Facial Sciences,

    Section of Orthodontics and Clinical Gnathology University of Naples Federico II, Naples, Italy,   §Department of Oral Diagnostic Sciences,

    University at Buffalo, Buffalo, NY, USA and   ¶Department of Clinical Oral Physiology, School of Dentistry, Aarhus University, Aarhus C,

    Denmark

    Introduction

    In the long history of temporomandibular disorders

    (TMD), the term ’’rehabilitation‘‘ has been often

    associated with ’’occlusal rehabilitation‘‘ indicating a

    specific philosophy in which occlusion is the crucial

    factor for TMD and that intervention on the occlusion

    could ’’cure‘‘ the problem. In this paper, the term

    rehabilitation is used to denote any medical, physical,

    or psychological treatment which brings or restores an

    individual to a normal or optimal state of health, and

    this revised concept therefore significantly broadens the

    scope of rehabilitation of TMD. The purpose of the JOR-

    CORE in Siena, 2009 was to critically examine the

    current state-of-the-science in the field of TMDs. This

    lead to four extensive reviews (1–4) and the present

    summaries and recommendations for future research

    into rehabilitation of TMDs.

    Pathophysiology of TMD

    State-of-the-science

    The pathophysiology of temporomandibular disorders

    (TMD) is complex and involves several mechanisms

    discussed in Cairns (1). The principal symptom of TMD

    that causes sufferers to seek medical care is pain in the

    temporomandibular joint (TMJ) and  ⁄  or masticatory

    muscles. Degenerative changes in the TMJ likely

    underlie pain in only a subgroup of patients with TMD

    and consequently there is often a poor correlation

     between the severity of pain complaints and patholog-

    ical changes in joint and muscle tissues. It has been

    demonstrated that some patients with TMD appear to

    have altered central nervous system pain processing and

    deficits in their ability to recruit endogenous analgesic

    mechanisms; collectively, these two central processes

    likely contribute to the development of chronic pain in

    certain individuals. Recent findings suggest that the

    propensity to develop chronic craniofacial pain may also

    result from genetic variability that leads to altered levels

    of neurotransmitters implicated in the activation and

    modulation of pain pathways. Stress reactivity, which

    may exert significant modulatory effects on pain

    processing, is recognized as an important factor for both

    the development and maintenance of pain in TMD and

    other chronic pain conditions. There is a greater

    prevalence of TMD amongst women, possibly related

    to sex hormones and in particular oestrogen, although

    how different sex hormones promote (or protect)

    against TMD pain is unknown and therefore remains

    an area of active research. Unfortunately, the specific

    mechanisms that underlie TMD-related pain in the vast

    majority of patients with TMD remain enigmatic.

    Recommendations

    The pathophysiology of TMD and its associated pain

    clearly requires a sound foundation of scientific knowl-

    edge, particularly with regard to its pathogenesis to

    permit the development of more rational and biologi-

    cally based approaches to diagnosis and treatment, but

    ª  2010 Blackwell Publishing Ltd doi: 10.1111/j.1365-2842.2010.02082.x

    Journal of Oral Rehabilitation   2010   37; 481–489

     J o u r n a l o f  Oral Rehabilitation

  • 8/18/2019 CAIRNS Et Al-2010-Journal of Oral Rehabilitation

    2/9

    despite extensive investigations, this has not yet been

    achieved. One area of scientific study that might bear

    fruit in this regard is the determination of predisposing

    factors for the development of TMD. For example, there

    are a number of interesting polymorphisms of genes that

    have been or may be associated with the development of

    chronic pain conditions. Catechol-O-methyl-tranferase

    (COMT) is one such gene  ⁄  gene product that has received

    much attention, while other possible candidates include

    serotonin transporters and oestrogen receptors which

    need to be characterized further. Other potential ‘bio-

    markers’ of TMD pain could include neuropeptides and

    neurotransmitters such as calcitonin gene-related pep-

    tide (CGRP) and serotonin. Large population-based

    prospective studies of patients with TMD and healthy

    controls, such as the ‘Orofacial Pain: Prospective Eval-

    uation and Risk Assessment’ (OPPERA) study currently

     being supported by the National Institute of Dental andCraniofacial Research in the US, will be necessary to

    screen for potential markers. Such studies, which focus

    on putative risks factors, will also be required not only to

    determine whether predictive markers are reliable but

    also to define possible mechanisms that regulate  ⁄  poten-

    tiate pain. Furthermore, influence of stress and stress

    hormones on nociceptive processing and clinical man-

    ifestation of TMD pain need to be better understood. It

    will not be possible to employ rational and biologically

     based treatments for TMD-related pain until these

    mechanisms are defined more clearly and precisely than

    they are now. This should lead to much more effective

    means for treatment and possibly prevention of TMD-

    related pain and dysfunction.

    Orthodontics, occlusion and TMD

    State-of-the-science

    The current literature does not support any strong

    associations between occlusal variables and TMD or any

    significant beneficial or detrimental effects of ortho-

    dontic interventions on manifest TMD pain (2). Twocaveats, however, need to be recognized.

    First, there is lack of specificity regarding the defini-

    tion of ‘occlusion’ and ‘malocclusion’. From a clinical

    point of view, malocclusion could be any occlusion in

    which the structural characteristics are different from

    those established for a theoretically ‘ideal’ occlusion.

    Although ‘ideal’ is difficult to define, a definition is

    undoubtedly necessary if rational treatment goals are to

     be established. It is also critical to recognize that even if

    ‘ideal’ has no bearing on what is ‘normal’ or ‘typical’ in

    terms of what is necessary for health, reconstruction of

    teeth (and supporting structures) according to ideal

    standards should be a target of treatment if treatment is

    indicated for other reasons, given that the boundary of

    what constitutes clinically acceptable is even harder to

    define. By extension, even if the prefix ‘mal’ means

    ‘bad’ or ‘ill’, the term ‘malocclusion’ does not neces-

    sarily imply that such an occlusion is non-physiologic

    or that therapy is indicated.

    Second, it is important to recognize that the term

    ‘TMD’ has been used, and still is used, very differently

    in the published literature; for example, the criteria

    used to denote presence or absence of TMD vary.

    Indeed, TMD is a very general term that defines a wide

    group of clinical entities (5), each with quite different

    and mostly unknown aetiology and pathophysiology(1) that only share in common the clinical features of

    producing pain and  ⁄  or functional limitation in the

    masticatory apparatus. Therefore, research protocols

    should continue to investigate well-defined subtypes

    without merging pain, joint sounds and  ⁄  or mechanical

    dysfunction as though those symptoms necessarily

    represent a single disorder.

    Recommendations

    While the current literature clearly supports the

    absence of a relationship between occlusion and TMD,

    definitional problems warrant further exploration of

    possible associations between occlusion and TMD. This

    recommendation is not made to suggest that such an

    association exists, but rather it is made in the interest of

    adhering to the principles of good science: methodo-

    logical problems that may underlie the absence of

    proposed relationships deserve further exploration.

    To pursue further exploration of any possible rela-

    tionship between occlusion and TMD, three develop-

    ments are needed: (i) the boundary between acceptable

    versus pathologic occlusion needs to be much betterdelineated; (ii) the existing occlusal variables that have

    already received much attention in published research

    need to be augmented by additional factors pertaining to

    the occlusion; and (iii) subtypes of TMD, which may

    have greater potential to be affected by structural factors,

    need to be defined based on mechanisms by which the

    putative structural factors would affect the subtypes and

    why specific subtypes might be more at risk.

    ª   2010 Blackwell Publishing Ltd

    B . C A I R N S   et al.482

  • 8/18/2019 CAIRNS Et Al-2010-Journal of Oral Rehabilitation

    3/9

    It is notable that most research regarding occlusion

    and TMD has been limited to structural characteristics

    associated with purely static occlusion (e.g. Angle’s

    classification) or with pre-defined aspects of articulation

    (e.g. so-called balancing interferences), assuming that

    there is necessarily some measurable functional corre-

    late or consequence of the identified characteristic. As

    more specific recommendations for further exploration,

    four directions are suggested. The first involves true

    dynamics of how structure and function interrelate

    (e.g. mastication where a bolus of food prevents actual

    tooth contact for the most part, or parafunctional

     behaviours involving direct tooth–tooth contact) which

    are poorly understood and clearly deserve more

    research to understand the relative contributions of

    structure and functional patterns to TMD onset or

    maintenance.

    The second direction involves symptom perceptionassociated with occlusal structures. Based on research

    in other areas of chronic pain (e.g. back pain), cognitive

    (e.g. catastrophizing), attentional (e.g. hypervigilance)

    and perceptual (symptom amplification) factors clearly

    contribute to psychophysiologic reactivity, treatment

    seeking and perpetuation of the condition. Of these,

    one factor in particular, hypervigilance – a state in

    which an individual, possibly because of a combination

    of predisposing genetic, psychosocial and environmen-

    tal factors, is exceedingly aware of the sensory experi-

    ence associated with a part of the body – merits

    investigation in association with occlusal variables.

    Hypervigilance is hypothesized to account for reported

    outcomes of occlusal treatment in patients with TMD

    where symptoms associated with the occlusion and, in

    particular, any modifications performed on the occlu-

    sion, independently of its anatomical or functional

    status, are predominant. Research and better under-

    standing of hypervigilance as a ‘perceptual habit’ in

    which attention is focused on sensations of a particular

    type with subjective amplification of perceptions will be

    needed. It can be speculated that hypervigilance,

    together with other psychological states such as anxietyor catastrophizing, could be a risk factor in patients with

    TMD when the therapeutic management includes a

    modification of the occlusion. Any alteration of the

    existing occlusal pattern (even if minimally invasive)

    may, especially in these patients, trigger a ‘bodily

    distress disorder’ (as has been termed in the back pain

    area), e.g. an occlusal dysesthesia disorder leading to

    further distress.

    A third direction warranting more research is the

    adaptive capability or resilience of the individual which

    could influence the definition of ‘normal’ as well as the

    results of any typical occlusal interventions provided to

    patients with dental restorative needs (or perhaps

    aesthetic needs) and who also have a TMD with, we

    assume, an external aetiology (e.g. trauma to the jaw).

    One testable hypothesis is that TMD causes irreversible

    degenerative alterations in the masticatory apparatus

    and, consequently, the system reacts with adaptive

    changes, in some cases also irreversible, in an attempt

    to regain the functional equilibrium. In this clinical

    situation, any occlusal modification procedure per-

    formed in these patients, even if appropriately indicated

    for occlusal rehabilitation purposes and technically

    correct, may exceed the adaptation capability of the

    system, the patient, or both, compromising the clinical

    status of the condition. Adaptation capability is impor-tant for all of dentistry, in that procedures regarded by

    the profession as routine may not be routine for a given

    individual, and consequently occlusal modification

    performed as part of an extensive plan of restorative

    treatment may exceed that capability and trigger the

    onset of an iatrogenic ‘TMD’.

    A fourth direction is the relation between occlusal

    characteristics and muscle activity. Hyperactivity of the

    masticatory apparatus may include both functional

    (chewing habitual food, chewing gum, tobacco, sun

    seeds) and ‘parafunctional’ oral habits, including but

    not restricted to non-functional tooth contacts; clench-

    ing and grinding of the teeth; biting of objects such as

    nails, fingers, or lips; and non-tooth contact behaviours

    such as bracing or thrusting the jaw. Carefully designed

    research projects are still needed to evaluate whether

    patients with waking-state or sleep-state non-func-

    tional tooth contacts are at higher risk of developing

    particular subtypes of TMD; what has not been consid-

    ered with this well-known question is whether the

    effects of these parafunctional behaviours occur per-

    haps in an occlusal-dependent manner. The current

    literature does not support the belief that occlusion perse influences the occurrence of non-functional tooth

    contacts; however, the interaction between occlusal

    variables and specific patterns associated with para-

    functional activity should be evaluated to determine

    (i) the boundaries of ‘normal’ for occlusal status;

    (ii) whether occlusal modifications in patients with

    TMD are more risky if the patient already has or is

    independently at risk for increased muscle activity

    ª   2010 Blackwell Publishing Ltd

    J O R - C O R E 2 0 0 9 R E C O M M E N D A T I O N S 483

  • 8/18/2019 CAIRNS Et Al-2010-Journal of Oral Rehabilitation

    4/9

    related to parafunctional behaviours; and (iii) whether

    otherwise non-TMD patients with increased muscle

    activity (e.g. the individual with chronic asymptomatic

    sleep-bruxism) are at higher risk of developing a TMD

    when undergoing an occlusal modification procedure.

    In conclusion, there is a need for critical thinking and

    careful planning of well-designed studies before the

    associations between occlusal variables and TMD are

    attempted to be (re)examined.

    Reviews of management of TMD pain

    State-of-the-science

    It is difficult for anyone to stay current with the

    constant growth of new scientific information and

    professional recommendations and to simultaneously

    evaluate the reliability, validity and applicability ofpublished results, and it is particularly difficult for full-

    time clinicians to do this (3). Dentists must find a way

    to manage this expanding mass of new knowledge – a

    way to filter and compile the information - so that it is

    clinically useful. Evidence-based medicine (EBM) is the

    integration of (i) best research evidence with (ii) clinical

    experience and (iii) patient values. These three ele-

    ments are essential to integrate to achieve optimal

    clinical outcome and quality of life for the patient.

    Clinicians and patients form a diagnostic and therapeu-

    tic alliance that has the potential to optimize clinical

    outcomes and quality of life.

    Our aim here is to focus on how EBM needs to be

    integrated in clinical practice, research settings and

    undergraduate teaching and to discuss benefits and

    limitations of clinical trials and systematic reviews

    (SRs).

    EBM in clinical and research settings   Two important

    elements in EBM, research evidence and clinical

    expertise, are nicely defined by Sackett   et al.   (6):

    (i) Best research evidence means clinically relevant

    research emerging not only from the basic sciences butalso from patient-centred clinical research regarding the

    accuracy and precision of diagnostic tests (including the

    clinical examination, prognostic markers, and the effi-

    cacy and safety of therapeutic, rehabilitative and

    preventive regimens) and (ii) clinical expertise is the

    ability to use our clinical skills and past experiences to

    rapidly identify each patient’s unique health state and

    diagnosis, their individual risks and benefits of potential

    interventions, and their personal values and expecta-

    tions.

    In EBM, evaluation of a patient and subsequent

    treatment decisions are a combination of (i) the

    available literature and investigations, (ii) clinical

    experience and (iii) the specific needs of each patient.

    It would seem obvious that in clinical practice, the EBM

    approach should benefit the patient. The question,

    however, is whether busy clinicians are prepared to use

    all three elements? How does the shortage of consistent

    scientific evidence affect implementation of treatment?

    How eager are clinicians to apply new knowledge and

    skills in clinical practice?

    One limitation to the practice of EBM is the gener-

    alizability of studies [e.g. randomized clinical trials

    (RCT), case–control studies] to the typical clinical

    setting. Studies often have very specific inclusion and

    exclusion criteria, which sometimes do not capture thetypical patient. Therefore, the generalizability from an

    RCT to the patient in the clinic may be unclear. Some

    instruments used extensively in research, such as the

    RDC  ⁄  TMD, are considered by some practitioners as

    time consuming and not always practical to use in a

     busy clinical practice. Standardized screening examina-

    tion procedures and short-form self-report instruments

    are a useful alternative approach for transferring to

    clinical practice some of the core principles used in

    clinical research.

    SRs, because they provide the best available research

    evidence for a specific issue, can be useful for clinicians

    and patients. Recommendations from SRs are not

    always conclusive, however, and consequently, SRs

    are likely to be most useful in excluding treatment

    strategies that are highly unlikely to be beneficial. This

    knowledge can be used in clinical decision-making and

    for educating the patient. One limitation is that clini-

    cians who are not trained in EBM would have problems

    advising and disseminating this information to the

    patient because it requires a significant shift in how one

    uses evidence and scientific logic.

    EBM in undergraduate education   The focus in EBM

    teaching has always been a patient-centred clinical

    situation. EBM emphasizes interactive, learner-centred

    activities for self-directed life-long learning. In under-

    graduate education, the major benefit of EBM is that

    students are taught how to think critically and ask

    themselves questions. One limitation is that because

    not all teachers are trained in evidence-based medicine,

    ª   2010 Blackwell Publishing Ltd

    B . C A I R N S   et al.484

  • 8/18/2019 CAIRNS Et Al-2010-Journal of Oral Rehabilitation

    5/9

    EBM is taught as a separate subject and not integrated

    into the curricula in the dental schools.

    Does EBM improve outcome for patients?    In the medical

    field, studies have reported that those patients who

    receive evidence-based therapies have better outcomes

    than those who do not. Although no RCT that focuses

    on that specific issue applied to TMD has been

    published, it is reasonable to assume that the findings

    from such studies in other areas are applicable to TMD,

    such that we can suggest that EBM does improve

    patient care for TMD. Economic conditions and med-

    ical insurance policies, however, may vary from

    country to country and profoundly influence the

    choice of treatment and its extensiveness. The treat-

    ment, as identified through EBM, is not always

    available to patients.

    The third important element in EBM is patient valuesand it was defined by Sackett   et al.   (6) as the unique

    preference, concerns and expectations each patient

     brings to a clinical encounter and which must be

    integrated into clinical decisions if they are to serve

    the patient. So the individual perspective, chief com-

    plaint, lifestyle, culture and expectations of each patient

    must be considered in selecting a particular treatment

    strategy.

     Methodological concerns in clinical trials   Common prob-

    lems in study design in several studies include small

    sample size, randomization, blinding and unreliable or

    non-patient-oriented measures. The results of investi-

    gations are not always generalisable because the

    patient’s condition, diagnosis and treatment differ from

    the features of patients and treatments normally found

    in clinical practice. Most studies relate their results to

    quantitative measures such as pain intensity, pain

    frequency, or medicine consumption, all of which are

    commonly accepted if not recommended therapeutic

    end-points for clinical trials but which are not neces-

    sarily the variables of greatest concern to a given

    patient. Qualitative research would be an alternativeapproach. If quantitative research methods best mea-

    sure the impact of TMD pain in a group, it may be

    that qualitative research best describes the impact of

    TMD pain in an individual. The aim of qualitative

    research is to understand the phenomena in natural

    rather than experimental settings, with an emphasis

    on understanding the experiences and values of our

    patients.

    Benefits and limitations of a SR   SRs are valuable because

    they provide a concise and easily read overview for

     both the clinician and researcher of the literature on a

    specific issue, and it provides a pool of readily identified

    quality studies. An SR can be used to educate and guide

    patients so that they more easily understand their

    condition and will adhere to treatment. However, the

    value of an individual SR cannot exceed the value of

    the studies being reviewed: if there are inherent

    limitations in the cited RCTs (e.g. generalizability

    problems), conclusions from the SR will be similarly

    limited. Additionally, if conclusions are mixed, the

    clinician will probably have to read the individual

    studies contained in the SR because one factor deter-

    mining the applicability of various research findings to

    a particular patient is the match in characteristics

     between the given patient and the subject pool of the

    particular study. Also, more recent studies or studiesthat were inadvertently not included in the SR could

    affect the recommendations.

    Benefits of SRs include the time they save by focusing

    on only quality studies and the possibility to exclude

    therapies that lack success or are harmful.

    Recommendations

    Research methods which allow patient-specific tailor-

    ing of treatment outcomes are needed. Such methods

    would weight those outcomes that are important for a

    particular patient more heavily than outcomes that

    are less important for that patient. For example, if

    patient #1 thought that better quality sleep was

    highly important, sleep measures would have higher

    weight in her outcome data than other measures that

    she considered less important; if patient #2 thought

    that pain-related affect was most important, this

    outcome measure would be weighted more highly

    than others. Such an approach might allow for

    research summaries that consider whether the inter-

    vention generally provided improvement in symptom

    areas that were most important for patients, evenif different patients weighted different outcomes

    differently.

    To minimize mistakes in study design, CONSORT

    recommendations should be followed by the researcher

    and required by all journals that publish clinical trials.

    Basic science studies should be designed in a manner

    likely to make them translatable into at least clinical

    research if not clinical practice. In a clinical research

    ª   2010 Blackwell Publishing Ltd

    J O R - C O R E 2 0 0 9 R E C O M M E N D A T I O N S 485

  • 8/18/2019 CAIRNS Et Al-2010-Journal of Oral Rehabilitation

    6/9

    setting, more evidence regarding accuracy and preci-

    sion of diagnostic tests is needed. In addition, more

    evidence is needed about TMD and the impact that

    TMD exerts on patients’ daily lives (see also Section on

    Disability).

    Knowledge regarding patient preferences with re-

    spect to treatments and the determinants of treatment

    compliance is currently limited. A qualitative meth-

    odological approach would probably shed some light

    on this issue and improve patient outcome measures.

    However, medical journals often will not publish

    qualitative studies because of reviewers having

    insufficient training and appreciation of qualitative

    methods.

    In a research setting, it is important that the assess-

    ment of treatment outcomes include multiple domains

    which together can capture a more comprehensive

    picture of the pain condition. For patients with TMDwith chronic pain, IMMPACT recommendations

    include these domains: pain; physical functioning;

    emotional functioning; participant rating of improve-

    ment and satisfaction with treatment, symptoms, and

    adverse events; and participant disposition (7). These

    domains are being modelled within the revision to the

    RDC  ⁄  TMD [see also Ohrbach  et al.  (8)].

    Disability

    State-of-the-science

    Limitation and disability is a major issue in TMD, and

    these concepts coupled with pathophysiology and

    impairment are collectively referred to as disable-

    ment (4). And, as Michelotti and Iodice (2) and Ohrbach

    (4) have shown, these concepts apply to other areas of

    dentistry as well. However, it seems to be a global

    challenge to incorporate the concept of disablement into

    dental education and dental clinical practice consistent

    with published descriptions of the problem. In addition,

    there is a lack of appreciation of the consequences of not

    addressing disability within dentistry (9). Given themagnitude of this challenge, the most streamlined

    approach for ready integration of disablement assess-

    ment into everyday clinical practice requires respect for

    and adherence to several key principles:

    1   Clinical practice is challenging with respect to both

    technical skills and clinical time management. At

    present, management of patients’ biomedical expecta-

    tions of dental treatment can be difficult. Transforming

    the practitioners’ practice to a biopsychosocial orienta-

    tion will, therefore, be even more demanding of skill

    and time. The question must therefore be posed as to

    how to train dentists in this skill?

    2   Any attempted assessment of disablement must be

    pragmatic and must transparently fit into any general

    dental setting.

    3  The outcome of the disablement assessment must be:

    unambiguous to the general dental practitioner; prac-

    tical within the context of an ongoing dental setting;

    and useful to the patient and the practitioner.

    A model already in use for assessing back painwhich incorporates the concept of red flags and

    yellow flags (10)1 to make disablement assessment a

    key part of primary medical care may have merit for

    providing a framework for assessing disablement in

    Initial or returning (new complaint) patient

    (Captive time in a waiting room)

    YesSignificant yellow flags

    warrant immediate concern ?

    Clinical evaluation:History – intervieaw for yellow flags

    Review screener responses and scores

    Patient completes screener for distress and social disability

    Refer for specialist

    consultation*

    No

    Proceed/continue treatment

    Making good progress

    Scheduled review (2–4 weeks)(rule-out red flags, monitor yellow flags)

    Yes

    * Minimal assessment protocol forlimitation and disability

    To be used in further evaluation by thetreating clinician (as appropriate) orby referral for specialist consultation:

    • pain • functional limitation • pain-related disability • depression • anxiety • non-specific (co-morbid) physical

    symptoms • oral HR-QoL

    No

    Rule-out red flags

    Re-evaluate 8 yellow flag areas

    Can provideraddress positive flags?

    Yes

    Modify treatment

    Red flags :investigate

    or refer

    No

    Scheduled review (2–4 weeks)

    (rule-out red flags, monitor yellow flags)

    Further evaluation or refer*

    Can provider

    address positive flags?

    No

    Yes

    Fig. 1.   Flow chart for routine incorporation of disablement

    assessment into general clinical practice and specialist referral.

    1Red flags identify potentially serious conditions such as pain that

    awakens the patient from sleep, drug addiction, or suicidal ideation

    that have immediate mortality or morbidity. Yellow flags identify

    psychosocial barriers to reasonable treatment response.

    ª   2010 Blackwell Publishing Ltd

    B . C A I R N S   et al.486

  • 8/18/2019 CAIRNS Et Al-2010-Journal of Oral Rehabilitation

    7/9

    everyday clinical practice. The ‘flag’ type of system

    should reduce the burden of such assessment within

    dentistry, thus ensuring that all patients in a given

    setting receive the same level of initial screening for

    limitation and disability. The screening and resultant

    presence or absence of flags would then determine

    whether or not a formal minimal assessment protocol

    for limitation and disability was indicated, thereby

    reducing the number of formal assessments that

    routine day-to-day dentistry might demand (see

    Fig. 1).

    Recommendations

    For implementing routine assessment of disablement

    status of individuals being evaluated and treated in

    dental settings, a stepped approach comprised of

    screening followed, as needed, by more formal assess-ment is recommended. A stepped approach is increas-

    ingly regarded as the most efficient method for

    collecting context-relevant information. Based on evi-

    dence from other areas of medicine, the screening stage

    should focus on the identification of yellow and red

    flags. Clinical data pertaining to flags can be easily

    obtainable in routine clinical dentistry using two

    methods for screening: (i) a standardized self-report

    instrument for information not readily obtained via

    other methods and (ii) clinical interview (history) for

    complaint-relevant information. The outcome of such

    information acquisition should then denote specific

    courses of action.

    The self-report instrument should examine, in no

    more than 20 items, distress and social disability.

    Distress and social disability were selected as useful

    screening constructs for disability as it was envisioned

    that they would capture significant elements of disabil-

    ity and handicap. A threshold, to be determined, in the

    self-report instrument would indicate whether it was

    necessary or appropriate (or not) to proceed with

    completion of the minimal formal disability assessment

    set to more accurately examine the level of disability ofthe patient in question. This is believed to be a

    pragmatic approach to the problem of disability assess-

    ment for the busy clinician, as not all patients will need

    a full disability assessment for every complaint. The

    distress portion of the instrument would also assess for

    significant problems such as suicidal ideation. The

    distress and social disability screening instrument needs

    to be further developed.

    The second method of determining flags is through

    the clinical interview (history). Implicit in this method

    is the need for additional educational and clinical

    training so that dental practitioners are comfortable

    and well versed with core psychosocial issues in a

    history. Some of the ‘flag’ areas that might be associated

    with history-taking and might merit further investiga-

    tion are:

    1 Chronicity. Determine the chronicity of the complaint;

    chronic pain, for example, is associated with greater

    likelihood of clinically significant depression and alter-

    ations in central nervous system processing of nocicep-

    tive stimuli.

    2   Functional limitation. Assess functional limitation

    status with regards to chewing, jaw mobility and use

    of the jaw for other functions; these areas would be

    explored via simple interview questions to determine

    whether the individual has such problems, and theexpected form of the responses need only be binary

    (yes, no) but could obviously be elaborated. For

    example, pain associated with a temporomandibular

    disorder should be accompanied by problems in jaw

    function as a minimum.

    3  Discrepancy in findings. Determine whether there is a

    discrepancy between reported symptoms versus ob-

    served findings; such discrepancies can point to signif-

    icant other factors contributing to the individual’s

    symptom report.

    4   Overuse of medication. Review medication history for

    prolonged or excessive use of opiates, benzodiazepines,

    alcohol, or other drugs.

    5   Inappropriate behavior . Observe for behaviour inap-

    propriate to the complaint; such behaviour can be

    explicit or implicit.

    6   Inappropriate expectations. Determine whether the

    patient’s expectations regarding character or outcome

    of treatment are unrealistic or inappropriate; such

    expectations on the part of the patient can point to a

    number of underlying problems that typically interfere

    with good health care delivery. Note that providers may

    also have unrealistic or inappropriate expectationsabout the presumed outcome of recommended treat-

    ment but that is a problem that needs attention

    elsewhere.

    7  Inappropriate responsiveness to (prior) treatment . Deter-

    mine whether prior treatment has been associated with

    inappropriate response in the patient’s symptoms; failed

    prior treatments do not bode well for the currently

    ª   2010 Blackwell Publishing Ltd

    J O R - C O R E 2 0 0 9 R E C O M M E N D A T I O N S 487

  • 8/18/2019 CAIRNS Et Al-2010-Journal of Oral Rehabilitation

    8/9

    planned therapy. This yellow flag is also assessed by

    the provider at each follow-up visit of his  ⁄  her own

    treatment.

    8   Identify red-flags from self-report screener . Suicidal

    ideation is one symptom within this portion of the

    evaluation that is a red flag and requires immediate

    action. Other possible red flags warrant further

    investigation and will be determined, for the most

    part, by the final content of the screener as well as by

    evolving standards for taking a history of pain

    complaints as well as by reviewing the medical

    history.

    The two methods for determining flags are imple-

    mented into a modification of the care system for a

    dental patient as shown diagrammatically in Fig. 1.

    While the minimal assessment procedures for screening

    via identification of yellow and red flags should

    contain, as bulleted in Fig. 1, assessment of multipleareas, it remains nevertheless lean, efficacious, effi-

    cient, easily integrated into procedures already per-

    formed, and highly sensitive.

    Implementation in clinical settings

    In reference to Fig. 1, stepped minimal disability

    assessment that includes administration of the stan-

    dardized screening instrument, interview questions,

    interpretation of psychosocial yellow flags (and

     biomedical red flags) and appropriate review at

    subsequent office visits would proceed as follows. A

    new patient, or a returning patient with a new

    complaint, completes the self-report distress and social

    disability screener and it is scored prior to the

    dentist’s exploration of the presenting complaint.

    The history-based yellow flags are explored during

    the history of complaint. These and any further

    positive flags are noted in the patient’s record. The

    number of yellow flags needed to trigger the use of

    the formal minimal disability protocol is not yet

    established, but clearly descriptive information asso-

    ciated with any positive yellow flags should enter intoclinical decision-making and possibly lead to stepped

    progression of the evaluation. Moreover, it would

    seem intuitive that any red flag should result in

    immediate attention for further investigation and or

    referral.

    At the first return visit progress via either symptom

    status or other measures could be assessed, and if the

    patient is flagged as having an inappropriate response to

    the treatment provided, then the provider should

    reconsider the diagnosis, treatment, or both. If inap-

    propriate response to treatment is flagged at this visit,

    the provider would also revisit all yellow flag screening

    items as well as exclude red flags. One more cycle of

    treatment could then be considered. If treatment now

    progresses well, the provider should continue with

    treatment and continue to monitor for red and yellow

    flags.

    If the second cycle of treatment does not proceed

    well, further diagnostic evaluation in the area of

    disablement is indicated; certainly other medical

    evaluation should be considered at this stage as well

    in that poor progress with treatment could be because

    of either medical or psychosocial factors, and   each

    should be further investigated at this stage without

    neglecting the other. This further investigation of

    psychosocial factors would be performed throughapplication of the minimal assessment protocol for

    limitation and disability. The initial provider can

    pursue this assessment, if prior training and experi-

    ence provide the necessary clinical skills, or the

    provider could refer the patient at this juncture to a

    specialist who has that training. These constructs

    would then be assessed by the specialist at the

     beginning of evaluation in lieu of using the distress

    and social disability screener.

    These recommendations, however, form a new per-

    spective that requires testing to obtain evidence for its

    validity and utility. Therefore, these recommendations

    entail: (i) instruments and instrument sets must be

    developed and thoroughly tested and (ii) extensive field

    testing of the practicality of the proposed protocol for

    assessing disability in dentistry must take place. This

    work is critical to ensure that any large scale changes

    made in the practice of clinical dentistry are evidence

     based and robust.

    Conclusions

    The present summaries and recommendations are based on the extensive reviews (1–4) and discussion

    within the four working groups during the JOR-

    CORE. Overall, these recommendations are based on

    current understanding of the published dental litera-

    ture, particularly as it relates to TMD pain, and

    provide a framework to move rehabilitation of not

    only patients with TMD but all dental patients

    forward.

    ª   2010 Blackwell Publishing Ltd

    B . C A I R N S   et al.488

  • 8/18/2019 CAIRNS Et Al-2010-Journal of Oral Rehabilitation

    9/9

    Acknowledgments

    The sponsors Wiley-Blackwell and Medotech Aps are

    thanked for their financial support to the JOR-CORE

    which would not have been possible without the

    financial aid.

    The authors, who are listed in alphabetical order,

    extend appreciation to the workgroup members for

    their valuable input and contributions to previous

    versions of this recommendation. The workgroup

    members were:

    Pathophysiology workgroup members

    Iva Alajbeg (Croatia), Altair Del Bel Cury (Brazil), Sibel

    Dincer (USA), Malin Ernberg (Sweden), Gary Heir

    (USA), Adriaan Klitsie (Netherlands), Howard

    Tenenbaum (Canada).

    Occlusion and orthodontic workgroup members

    Taro Arima (Japan), Jose Luis de la Hoz (Spain),

    Susanne Elmasry Ivanovic (Sweden), Malvin Janal

    (USA), Pinar Kursoglu (Turkey), Tomohiro Tanosoto

    (Japan), Ephraim Winocur (Israel), Luo Xiaoping

    (China).

    Systematic review workgroup members

    Jari Ahlberg (Fin), Maria Clotilde Carra (Italy),

    Fernanda Foat (Brazil), Nikolaos Giannakopoulos

    (Germany), Ebru Ispirgil (Turkey), Karen Raphael

    (USA), Claudia Restrepo (Columbia), Olcay Sakar

    (Turkey).

    Disability workgroup members

    Justin Durham (UK), Anat Gavish (Israel), Jordi

    Martinez-Gomis (Spain), Yoshihiro Tsukiyama (Japan),

    Wataru Yachida (Japan).

    References

    1. Cairns BE. Pathophysiology of TMD pain - basic mechanisms

    and their implications for pharmacotherapy. J Oral Rehabil.

    2010;37:391–410.

    2. Michelotti A, Iodice G. The role of orthodontics in tempor-

    omandibular disorders. J Oral Rehabil. 2010;37:411–429.

    3. List T, Axelsson S. Management of TMD: Evidence from

    systematic reviews and meta-analyses. J Oral Rehabil. 2010;

    37:430–451.

    4. Ohrbach R. Disability assessment in temporomandibular dis-

    orders and masticatory system rehabilitation. J Oral Rehabil.

    2010;37:452–480.

    5. Dworkin SF, LeResche L. Research diagnostic criteria for

    temporomandibular disorders: review, criteria, examinations

    and specifications, critique. J Craniomandib Disord Facial Oral

    Pain. 1992;6:301–355.

    6. Sackett D, Straus S, Ws R, Rosenberg W, Haynes R. Evidence-

     based medicine. How to practice and teach EBM. Edinburgh:

    Churchill Livingstone, 2000.

    7. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, JensenMP, Katz NP, et al. Core outcome measures for chronic pain

    clinical trials: IMMPACT recommendations. Pain. 2005;113:

    9–19.

    8. Ohrbach R, List T, Goulet J-P, Svensson P. Recommendations

    from the International Consensus Workshop: Convergence on

    an Orofacial Pain Taxonomy. J Oral Rehabil. 2010; In press.

    9. Locker D. Measuring oral health: a conceptual framework.

    Community Dental Health. 1987;5:3–18.

    10. New Zealand Guidelines Group. New Zealand Low Back Pain

    Guide. 2004. Wellington, New Zealand.

    Correspondence: Svensson P, Department of Clinical Oral Physiology,

    School of Dentistry, Aarhus University, 8000 Aarhus C, Denmark.

    Email: [email protected]

    ª   2010 Blackwell Publishing Ltd

    J O R - C O R E 2 0 0 9 R E C O M M E N D A T I O N S 489